Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) has entered into a five-year agreement with SOMAÍ Pharmaceuticals, to supply its operations in Portugal with EU-GMP certified CBD extracts from Colombia.

With the first shipments under the agreement already completed, Clever Leaves will continue to supply EU-GMP pharmaceutical-grade APIs and CBD extracts, produced in the company’s facility in Colombia, to SOMAÍ for further processing into finished products for patients across Europe. These are the first commercial shipments Clever Leaves has sent to Portugal, adding to the more than 15 countries …

Full story available on

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.